Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT00153920
Brief Title:
Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
Official Title:
Phase II Trial of Velcade (Bortezomib) in Patients With Previously Untreated Multiple Myeloma
Study:
NCT00153920
Protocol Section:
NCT00153920